{
    "title": "Merck CEO sees Keytruda in pole position in cancer race",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-4137028/Merck-CEO-sees-Keytruda-pole-position-cancer-race.html",
    "date": "2017-01-19",
    "keywords": [
        "combination",
        "cancer",
        "drug",
        "chemotherapy",
        "lung",
        "merck",
        "ceo",
        "position",
        "race",
        "gmt",
        "week",
        "review",
        "therapy",
        "fact",
        "price",
        "email",
        "ben",
        "hirschlerdavos",
        "jan",
        "speedy",
        "use",
        "market",
        "companys",
        "executive",
        "frazier",
        "keytruda",
        "consideration",
        "era",
        "controversy",
        "food",
        "administration",
        "fda",
        "marketthe",
        "drugmaker",
        "world",
        "forum",
        "progress",
        "surprise",
        "trial",
        "october",
        "phase",
        "iii",
        "study",
        "filing",
        "treatment",
        "effect",
        "immunooncology",
        "io",
        "astrazeneca",
        "cancerthat",
        "point",
        "benefit",
        "healthcare",
        "system",
        "europe",
        "health",
        "attentionwith",
        "presidentelect",
        "donald",
        "trump",
        "murder",
        "challenge",
        "industrysome",
        "percent",
        "feel",
        "suit",
        "goodman"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}